Osaic Holdings
KZR

Osaic Holdings’s Kezar Life Sciences KZR Stock Holding History

Osaic Holdings’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-94
Closed -$591 – 7957
2025
Q4 		$591 Buy
94
+4
+4% +$23 ﹤0.01% 7411
2025
Q3 		$323 Hold
90
– – ﹤0.01% 7623
2025
Q2 		$412 Buy
90
+86
+2,150% +$369 ﹤0.01% 7381
2025
Q1 		$20 Sell
4
-465
-99% -$2.82K ﹤0.01% 7347
2024
Q4 		$3.15K Buy
469
+2
+0.4% +$15 ﹤0.01% 6424
2024
Q3 		$3.6K Buy
467
+369
+377% +$2.23K ﹤0.01% 6367
2024
Q2 		$588 Buy
98
+90
+1,125% +$684 ﹤0.01% 6943
2024
Q1 		$68 Sell
8
-6
-43% -$55 ﹤0.01% 7065
2023
Q4 		$127 Hold
14
– – ﹤0.01% 7092
2023
Q3 		$160 Hold
14
– – ﹤0.01% 7184
2023
Q2 		$331 Sell
14
-50
-78% -$1.3K ﹤0.01% 7127
2023
Q1 		$1.99K Sell
64
-165
-72% -$9.55K ﹤0.01% 6717
2022
Q4 		$16K Hold
229
– – ﹤0.01% 5712
2022
Q3 		$20K Buy
229
+5
+2% +$486 ﹤0.01% 5580
2022
Q2 		$18K Buy
224
+210
+1,500% +$18.5K ﹤0.01% 5685
2022
Q1 		$2K Hold
14
– – ﹤0.01% 6887
2021
Q4 		$2K Buy
+14
New +$1.58K ﹤0.01% 7024

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Osaic Holdings's KZR Position: Q1 2026 in Review

Osaic Holdings sold out of Kezar Life Sciences (KZR) in Q1 2026, closing a stake of 94 shares — an estimated $591 sold.

Osaic Holdings first reported a position in KZR in Q4 2021 and held it in 17 quarters. The position peaked at $20K in Q3 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Osaic Holdings reported no remaining Kezar Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 94 Kezar Life Sciences shares in Q1 2026, an estimated $591.
  • Osaic Holdings first reported a position in Kezar Life Sciences in Q4 2021 and held it in 17 quarters.
  • Osaic Holdings's Kezar Life Sciences position peaked at $20K in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.